Φορτώνει......
Current and emerging biomarkers in metastatic colorectal cancer
BACKGROUND: The incorporation of novel biomarkers into therapy selection for patients with metastatic colorectal cancer (mcrc) has significantly improved outcomes. Optimal treatment planning now takes into account diverse characteristics of patients and their tumours to create personalized therapeut...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Oncol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Multimed Inc.
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6878935/ https://ncbi.nlm.nih.gov/pubmed/31819705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.5719 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|